Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 A Randomized Platform Trial
MD, PhD; Gilmar Reis, Eduardo Augusto, Moreira Santos, MD, PhD; Daniela Silva, Medeiros Carla, MD Silva, PhD Lehana Thabane, PhD Vitoria Helena, Souza Campos, ; Thiago, MD Santiago Ferreira, Castilho Vitor Quirino, Ana Santos, Ribeiro Maria, MD Ana Paula Nogueira, Guimaraes Figueiredo, MD Leonardo Almeida, Monteiro Cançado, MD Savassi, PhD Adhemar Dias, MD, PhD Figueiredo Neto, RN Carina Bitarães, RN Aline Cruz Milagres, MD ; Eduardo Diniz Callegari, Maria Izabel Campos Simplicio, Bscpharm ; Luciene, RN, MPH Barra Ribeiro, Rosemary Oliveira, PhD Ofir Harari, MSc Lindsay A Wilson, PhD, MPH Jamie I Forrest, MSc Hinda Ruton, PhD Sheila Sprague, MSc Paula Mckay, Christina M Guo, MD Gordon H Guyatt, PharmD Craig R Rayner, MD, MPH David R Boulware, MDCM, MPH Nicole Ezer, MD, MPH Todd C Lee, MD, MSc Emily Gibson Mcdonald, MBChB Mona Bafadhel, PhD Christopher Butler, MD Josue Rodrigues Silva, MD, MSc Mark Dybul, MD Edward J Mills
doi:10.7326/M22-3305
Background: Previous trials have demonstrated the effects of fluvoxamine alone and inhaled budesonide alone for prevention of disease progression among outpatients with COVID-19. Objective: To determine whether the combination of fluvoxamine and inhaled budesonide would increase treatment effects in a highly vaccinated population.
Author contributions are available at Annals.org.
References
Bramante, Huling, Tignanelli, Randomized trial of metformin, ivermectin, and fluvoxamine for covid-19, N Engl J Med,
doi:10.1056/NEJMoa2201662
Guo, Harari, Chernecki, Fluvoxamine for the early treatment of COVID-19: A meta-analysis of randomized clinical trials, Am J Trop Med Hyg,
doi:10.4269/ajtmh.21-1310
Guo, Harari, Chernecki, Fluvoxamine for the early treatment of COVID-19: A meta-analysis of randomized clinical trials, Am J Trop Med Hyg,
doi:10.4269/ajtmh.21-1310
Lee, Vigod, Bortolussi-Courval, Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: A systematic review and meta-analysis, JAMA Netw Open,
doi:10.1001/jamanetworkopen.2022.6269
Lenze, Mattar, Zorumski, Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: A randomized clinical trial, JAMA,
doi:10.1001/jama.2020.22760
Mills, Thorlund, Ioannidis, Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies, J Clin Epidemiol,
doi:10.1016/j.jclinepi.2012.07.012
Omi, Tanimukai, Kanayama, Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor, Cell Death Dis,
doi:10.1038/cddis.2014.301
Park, Siden, Zoratti, Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of ORIGINAL RESEARCH Oral Fluvoxamine With Inhaled Budesonide for Early-Onset COVID-19 master protocols, Trials,
doi:10.1186/s13063-019-3664-1
Reis, Santos Moreira, Silva, Medeiros Silva, Thabane et al., Oral Fluvoxamine With Inhaled Budesonide for Early-Onset COVID-19 ORIGINAL RESEARCH Annals.org Author Contributions: Conception and design
Reis, Santos Moreira-Silva, Silva, Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial, Lancet Glob Health,
doi:10.1016/S2214-109X(21)00448-4
Reis, Santos, Silva, Silva, Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial, Lancet Reg Health Am,
doi:10.1016/j.lana.2021.100142
Reis, Silva, Silva, A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol, Gates Open Research
Reis, Silva, Silva, A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol, Gates Open Research
Reis, Silva, Silva, Effect of early treatment with hydroxychloroquine or lopinavir and ritonavir on risk of hospitalization among patients with COVID-19: the TOGETHER randomized clinical trial, JAMA Netw Open,
doi:10.1001/jamanetworkopen.2021.6468
Reis, Silva, Silva, Effect of early treatment with ivermectin among patients with covid-19
Schandelmaier, Briel, Varadhan, Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and metaanalyses, CMAJ,
doi:10.1503/cmaj.200077
Sukhatme, Reiersen, Vayttaden, Fluvoxamine: A review of its mechanism of action and its role in COVID-19, Front Pharmacol,
doi:10.3389/fphar.2021.652688
Woodcock, Lavange, Master protocols to study multiple therapies, multiple diseases, or both, N Engl J Med,
doi:10.1056/NEJMra1510062
Yu, Bafadhel, Dorward, Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial, Lancet,
doi:10.1016/S0140-6736(21)01744-X